BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
7.79
-0.23 (-2.87%)
At close: Oct 16, 2026, 4:00 PM EDT
7.75
-0.04 (-0.51%)
After-hours: Oct 16, 2026, 7:30 PM EDT
BioCryst Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Reiterates $15 | Buy | Reiterates | $15 | +92.55% | Oct 9, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $11 | Hold | Maintains | $11 | +41.21% | Oct 9, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Reiterates $12 → $13 | Hold | Reiterates | $12 → $13 | +66.88% | Sep 30, 2026 |
| Needham | Needham | Buy Maintains $16 | Buy | Maintains | $16 | +105.39% | Sep 8, 2026 |
Unknown Analyst Evercore ISI No rating | Evercore ISI | Buy Maintains $17 | Buy | Maintains | $17 | +118.23% | Aug 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $32 | Buy | Maintains | $32 | +310.78% | Aug 6, 2026 |
| Wedbush | Wedbush | Buy Maintains $20 | Buy | Maintains | $20 | +156.74% | Aug 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $30 | Buy | Maintains | $30 | +285.11% | Aug 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.